What is QFR During Cardiac Catheterization?
QFR (Quantitative Flow Ratio) is a wire-free, angiography-based technology that calculates the functional significance of coronary stenoses using 3D reconstruction from standard coronary angiography images, without requiring pressure wires or hyperemic agents. 1
How QFR Works
QFR derives coronary pressure measurements through computational analysis of routine angiographic images. The technology creates a 3D coronary artery model and applies computational fluid dynamics to estimate the pressure drop across a stenosis, essentially providing the same information as FFR but without invasive wire placement 1.
The key advantage is that QFR provides both distal coronary pressure measurements AND a complete pressure map along the entire coronary vessel—all from angiographic images alone. 1
Clinical Application and Guideline Recommendations
The 2024 ESC Guidelines give QFR a Class I, Level B recommendation for assessing intermediate coronary stenoses during catheterization, with a threshold of ≤0.80 indicating hemodynamically significant disease. 1
This places QFR alongside FFR/iFR as a recommended technique for functional assessment, though FFR/iFR carry slightly stronger evidence (Class I, Level A) 1.
When to Use QFR
- Intermediate stenoses (typically 40-90% diameter stenosis by visual estimation)
- When functional assessment is needed but wire-based measurement is unavailable, technically challenging, or undesirable
- Particularly useful in calcified lesions where wire passage may be difficult 2
- Helpful for serial lesions or diffuse CAD where pressure mapping along the vessel provides additional information 1
Important Performance Characteristics
QFR demonstrates strong diagnostic accuracy:
- Sensitivity: 82.6% for detecting FFR-significant stenosis 3
- Specificity: 91.9% 3
- Overall diagnostic accuracy: 92.7% compared to FFR 4
- Area under the curve: 0.94 3
Clinical Outcome Data
The FAVOR III China study demonstrated that QFR-guided revascularization improved clinical outcomes compared to angiography alone, with fewer myocardial infarctions and ischemia-driven revascularizations. 1 This outcome data was critical for QFR's guideline inclusion, as the ESC explicitly states that validation against FFR alone is insufficient—direct clinical outcome benefit must be demonstrated 1.
QFR Variants
Multiple QFR calculation methods exist 3:
- μQFR (Murray law-based): Highest diagnostic performance, uses physiologic flow distribution principles
- cQFR (contrast-flow): Uses contrast flow velocity
- fQFR (fixed-flow): Assumes standardized flow rates
- aQFR (adenosine-flow): Incorporates adenosine administration
μQFR demonstrates superior diagnostic accuracy with an adjusted diagnostic odds ratio of 126.25 compared to other variants 3.
Key Limitations and Pitfalls
Technical Considerations
- Requires adequate angiographic image quality with multiple projections (typically two views at least 25° apart)
- Cannot be calculated in approximately 10-15% of cases due to poor image quality, vessel overlap, or inadequate opacification 5
- Bifurcation lesions show higher discordance with invasive measurements 6
- Shorter lesions may have reduced concordance with wire-based indices 6
Clinical Caveats
- QFR tends to underestimate ischemia in 14.9% of cases (false negatives) compared to non-hyperemic pressure ratios 6
- The negative predictive value is excellent (97.1%), making QFR particularly useful for safely excluding significant stenosis 4
- Positive predictive value is lower (85.5%), so positive QFR results may warrant confirmation with wire-based assessment in borderline cases 4
Practical Implementation
QFR can be calculated offline after the catheterization procedure, which is a unique advantage—you can retrospectively analyze lesions without needing to make real-time decisions about wire placement 5. This allows for:
- Post-procedure review of deferred lesions
- Multidisciplinary team discussions before staged procedures
- Assessment when wire-based measurement was not initially performed
Contraindications to Systematic Use
Do NOT perform systematic QFR (or any functional assessment) of all vessels in multivessel disease—the RIPCORD2 and FUTURE trials showed no clinical benefit versus angiography alone for this approach 1. Limit functional assessment to intermediate lesions where the revascularization decision is genuinely uncertain.
Integration with Other Modalities
When QFR and invasive indices disagree, consider:
- Lesion anatomy: Bifurcations, very short lesions, or diffuse disease may benefit from wire-based confirmation
- Combined pressure-flow assessment: Adding CFR or microvascular assessment may clarify discordant results 1
- Intravascular imaging: OCT or IVUS can provide complementary anatomic information
QFR represents a validated, wire-free alternative for functional coronary assessment that improves outcomes compared to angiography alone, with particular utility when wire-based measurement is impractical or when offline analysis is preferred.